clonazepam has been researched along with Anxiety Disorders in 59 studies
Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
clonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.
Anxiety Disorders: Persistent and disabling ANXIETY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine whether etifoxine, a non-benzodiazepine drug of the benzoxazine family, is non-inferior compared with clonazepam in the treatment of anxiety disorders." | 9.34 | Etifoxine is non-inferior than clonazepam for reduction of anxiety symptoms in the treatment of anxiety disorders: a randomized, double blind, non-inferiority trial. ( Bustos, C; Hormazabal, N; Rubí, P; Saldivia, S; Vicente, B, 2020) |
| "A randomized, double-blind controlled trial is reported comparing phenobarbital and clonazepam for the purpose of sedative-hypnotic taper in inpatients with chronic, nonmalignant pain." | 9.07 | Phenobarbital versus clonazepam for sedative-hypnotic taper in chronic pain patients. A pilot study. ( Lynn, P; Roy-Byrne, P; Sullivan, M; Toshima, M, 1993) |
| "The response to treatment with imipramine or clonazepam was evaluated in patients with panic disorder." | 7.68 | [Treatment of patients with panic disorder and an elevated urinary excretion of MHPG using imipramine or clonazepam]. ( Carreira, I; Casique, M; Lima, L; Morales, M; Silva, C, 1992) |
| "Clonazepam, a high-potency benzodiazepine marketed for the treatment of minor motor epilepsy, was used to treat 50 patients with panic disorder (N = 22) or agoraphobia with panic attacks (N = 28)." | 7.67 | Treatment of panic disorder and agoraphobia with clonazepam. ( Rosenbaum, JF; Spier, SA; Tesar, GE; Woods, SW, 1986) |
| "Fifty patients with panic disorder or agoraphobia with panic attacks with treated with clonazepam, a high potency benzodiazepine." | 7.67 | Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up. ( Pollack, MH; Rosenbaum, JF; Spier, SA; Tesar, GE, 1986) |
| "To determine whether etifoxine, a non-benzodiazepine drug of the benzoxazine family, is non-inferior compared with clonazepam in the treatment of anxiety disorders." | 5.34 | Etifoxine is non-inferior than clonazepam for reduction of anxiety symptoms in the treatment of anxiety disorders: a randomized, double blind, non-inferiority trial. ( Bustos, C; Hormazabal, N; Rubí, P; Saldivia, S; Vicente, B, 2020) |
| "A randomized, double-blind controlled trial is reported comparing phenobarbital and clonazepam for the purpose of sedative-hypnotic taper in inpatients with chronic, nonmalignant pain." | 5.07 | Phenobarbital versus clonazepam for sedative-hypnotic taper in chronic pain patients. A pilot study. ( Lynn, P; Roy-Byrne, P; Sullivan, M; Toshima, M, 1993) |
| " Clonazepam, with its relatively long half-life, permits less frequent dosing than possible with benzodiazepines with shorter half-lives and more continuous control of anxiety, although around 20% of patients experience unacceptable sedative effects or no reduction in anxiety." | 3.76 | High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience. ( Tesar, GE, 1990) |
| "Clonazepam has been chosen for further study because in adults it reduced panic attacks and produced few serious side effects." | 3.76 | High anxiety in children. ( Graae, F, 1990) |
| "The response to treatment with imipramine or clonazepam was evaluated in patients with panic disorder." | 3.68 | [Treatment of patients with panic disorder and an elevated urinary excretion of MHPG using imipramine or clonazepam]. ( Carreira, I; Casique, M; Lima, L; Morales, M; Silva, C, 1992) |
| " The authors present three patients with alcoholism in whom diagnosis of panic was facilitated by intravenous lactate infusion, and whose symptoms were alleviated by clonazepam." | 3.68 | The diagnosis and treatment of panic disorder in alcoholics: three cases. ( Baron, DH; Ciraulo, DA; Sands, BF; Shader, RI, 1990) |
| " She was given 25 mg of intramuscular diphenhydramine and 1 mg of intramuscular benztropine mesylate, which resulted in little relief; however, 1 mg clonazepam caused both the myoclonic jerks and dystonias to resolve completely." | 3.67 | Acute generalized myoclonus following buspirone administration. ( Bridenbaugh, RH; Jabbari, B; Ritchie, EC, 1988) |
| "Three prepubertal children who suffered severe, incapacitating anxiety disorders with panic-like symptoms were treated successfully with clonazepam." | 3.67 | Clonazepam in the treatment of prepubertal children with panic-like symptoms. ( Biederman, J, 1987) |
| "Clonazepam, a high-potency benzodiazepine marketed for the treatment of minor motor epilepsy, was used to treat 50 patients with panic disorder (N = 22) or agoraphobia with panic attacks (N = 28)." | 3.67 | Treatment of panic disorder and agoraphobia with clonazepam. ( Rosenbaum, JF; Spier, SA; Tesar, GE; Woods, SW, 1986) |
| "Ten cases are presented--two in detail--in which clonazepam was used successfully in patients with treatment-resistant panic disorder with or without agoraphobia." | 3.67 | Successful use of clonazepam in patients with treatment-resistant panic disorder. ( Rosenbaum, JF; Tesar, GE, 1986) |
| "Fifty patients with panic disorder or agoraphobia with panic attacks with treated with clonazepam, a high potency benzodiazepine." | 3.67 | Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up. ( Pollack, MH; Rosenbaum, JF; Spier, SA; Tesar, GE, 1986) |
| "Add-on effect of Shirodhara reduced the daytime sleepiness." | 2.77 | Clinical efficacy of Manasamitra Vataka (an Ayurveda medication) on generalized anxiety disorder with comorbid generalized social phobia: a randomized controlled study. ( Chandrashekar, CR; Kutty, BM; Lavekar, GS; Prabha, TN; Sudhakar, D; Tubaki, BR, 2012) |
| "Clonazepam was administered in relatively low doses and, after four weeks, was shown to be effective in reducing the number of panic attacks and associated features of the disorder." | 2.67 | Low doses of clonazepam in the treatment of panic disorder. ( de Loof, C; Griez, E; Lousberg, H; Pols, H; Zandbergen, J, 1991) |
| "Sedation and ataxia were the most common side effects reported, but these effects were mild and transient and did not interfere with treatment outcome." | 2.67 | Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. ( Cohen, LS; Herman, JB; Otto, MW; Pollack, MH; Rosenbaum, JF; Sachs, GS; Spier, SA; Tesar, GE, 1991) |
| "Many patients with migraine are poorly responsive to conventional preventive therapies." | 2.46 | Clonazepam for refractory headache: three cases illustrative of benefit and risk. ( Maizels, M, 2010) |
| "Clonazepam has shown some efficacy in social phobia; however, because this evidence is based on few studies, further studies are warranted before definitive conclusions can be drawn." | 2.43 | Clonazepam in the treatment of psychiatric disorders: an update. ( Nardi, AE; Perna, G, 2006) |
| " Eighty-two percent (39) of the patients rated clonazepam as being "better" than alprazolam due to decreased dosing frequency and lack of interdose anxiety." | 2.37 | Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines. ( Brotman, AW; Herman, JB; Rosenbaum, JF, 1987) |
| "The patient's level of dissociation was measured using the Dissociative Experiences Scale-II (DES-II)." | 1.37 | EEG complexity and attentional processes related to dissociative states. ( Bob, P; Epstein, P; Golla, M; Konopka, L, 2011) |
| "Patients with Tourette's syndrome often develop multiple psychopathological symptoms beyond the basic symptoms (motor and vocal tics)." | 1.31 | [Disguised Tourette's syndrome. A contribution to the differential diagnosis on phobia and fear]. ( Barnett, W; Bednarz, K; Haisch, S, 2002) |
| "Clonazepam is a high-potency 1,4-benzodiazepine derivative with an intermediate to long elimination half-life that is used mainly in neurology as an antiepileptic." | 1.27 | Clonazepam in the treatment of patients with recurrent panic attacks. ( Annable, L; Beaudry, P; Chouinard, G; Fontaine, R, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (32.20) | 18.7374 |
| 1990's | 28 (47.46) | 18.2507 |
| 2000's | 6 (10.17) | 29.6817 |
| 2010's | 4 (6.78) | 24.3611 |
| 2020's | 2 (3.39) | 2.80 |
| Authors | Studies |
|---|---|
| Vicente, B | 1 |
| Saldivia, S | 1 |
| Hormazabal, N | 1 |
| Bustos, C | 1 |
| Rubí, P | 1 |
| Lohiya, N | 2 |
| Karve, S | 1 |
| Agarkhedkar, S | 1 |
| Lin, CC | 1 |
| Lin, PY | 1 |
| Lee, Y | 1 |
| Chang, YY | 1 |
| Chen, CH | 1 |
| Maizels, M | 1 |
| Bob, P | 1 |
| Golla, M | 1 |
| Epstein, P | 1 |
| Konopka, L | 1 |
| Estabrook, KR | 1 |
| Pheister, M | 1 |
| Tubaki, BR | 1 |
| Chandrashekar, CR | 1 |
| Sudhakar, D | 1 |
| Prabha, TN | 1 |
| Lavekar, GS | 1 |
| Kutty, BM | 1 |
| Bednarz, K | 1 |
| Haisch, S | 1 |
| Barnett, W | 1 |
| Blanco, C | 1 |
| Schneier, FR | 2 |
| Schmidt, A | 1 |
| Blanco-Jerez, CR | 1 |
| Marshall, RD | 1 |
| Sánchez-Lacay, A | 1 |
| Liebowitz, MR | 2 |
| Oberlander, TF | 1 |
| Misri, S | 1 |
| Fitzgerald, CE | 1 |
| Kostaras, X | 1 |
| Rurak, D | 1 |
| Riggs, W | 1 |
| Rosenbaum, JF | 13 |
| Nardi, AE | 1 |
| Perna, G | 1 |
| Chouinard, G | 4 |
| Labonte, A | 1 |
| Fontaine, R | 3 |
| Annable, L | 2 |
| Hertrich, O | 1 |
| Sullivan, M | 1 |
| Toshima, M | 1 |
| Lynn, P | 1 |
| Roy-Byrne, P | 1 |
| Friedenberg, FK | 1 |
| Rothstein, KD | 1 |
| Serra-Mestres, J | 1 |
| Shapleske, J | 1 |
| Tym, E | 1 |
| de Carle, AJ | 1 |
| Pato, MT | 1 |
| Clarvit, SR | 1 |
| Freeman, S | 1 |
| Gelpin, E | 1 |
| Bonne, O | 1 |
| Peri, T | 1 |
| Brandes, D | 1 |
| Shalev, AY | 1 |
| Hulstrand, EP | 1 |
| Boshes, RA | 1 |
| Afonso, JA | 1 |
| Tanev, K | 1 |
| Lima, L | 1 |
| Carreira, I | 1 |
| Morales, M | 1 |
| Silva, C | 1 |
| Casique, M | 1 |
| Diukova, GM | 1 |
| Shepeleva, IP | 1 |
| Vorob'eva, OV | 1 |
| Pols, H | 1 |
| Zandbergen, J | 1 |
| Lousberg, H | 1 |
| de Loof, C | 1 |
| Griez, E | 1 |
| Karagianis, JL | 1 |
| March, H | 1 |
| Pollack, MH | 7 |
| Biederman, J | 2 |
| Tesar, GE | 6 |
| Otto, MW | 2 |
| Sachs, GS | 3 |
| Herman, JB | 4 |
| Cohen, LS | 3 |
| Spier, SA | 3 |
| Geracioti, TD | 1 |
| Post, RM | 1 |
| Fava, M | 2 |
| Borofsky, GF | 1 |
| Svebak, S | 1 |
| Cameron, A | 1 |
| Levander, S | 1 |
| Graae, F | 1 |
| Reiter, SR | 1 |
| O'Neil, C | 1 |
| Asher, R | 1 |
| Meltzer-Brody, S | 1 |
| Davidson, JR | 1 |
| Eppel, AB | 2 |
| Baron, DH | 1 |
| Sands, BF | 1 |
| Ciraulo, DA | 1 |
| Shader, RI | 1 |
| Anderson, K | 1 |
| Balon, R | 1 |
| Ramesh, C | 1 |
| Pohl, R | 1 |
| Bodkin, JA | 1 |
| White, K | 1 |
| Brotman, AW | 2 |
| Beckett, A | 1 |
| Fishman, SM | 1 |
| Mahoney, EM | 1 |
| McNamara, M | 1 |
| Goldstein, S | 1 |
| Ritchie, EC | 1 |
| Bridenbaugh, RH | 1 |
| Jabbari, B | 1 |
| Patterson, JF | 1 |
| Woods, SW | 1 |
| Beaudry, P | 1 |
| Jones, BD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Early Pharmacological Intervention With Diazepam in the Emergency Room Setting to Prevent Posttraumatic Stress Disorder (PTSD).[NCT01221883] | Phase 4 | 40 participants (Anticipated) | Interventional | 2013-05-31 | Active, not recruiting | ||
| The Role of Orexin in Human Panic Disorder[NCT02593682] | Phase 4 | 3 participants (Actual) | Interventional | 2016-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for clonazepam and Anxiety Disorders
| Article | Year |
|---|---|
Clonazepam for refractory headache: three cases illustrative of benefit and risk.
Topics: Adult; Anxiety Disorders; Clonazepam; Comorbidity; Depressive Disorder; Drug Tolerance; Female; GABA | 2010 |
Pharmacological treatment of social anxiety disorder: a meta-analysis.
Topics: Acetates; Amines; Anti-Anxiety Agents; Antidepressive Agents; Antimanic Agents; Anxiety Disorders; C | 2003 |
The development of clonazepam as a psychotropic: the massachusetts general hospital experience.
Topics: Anxiety Disorders; Clonazepam; Hospitals, General; Humans; Massachusetts; Psychotropic Drugs; Resear | 2004 |
Clonazepam in the treatment of psychiatric disorders: an update.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Bipolar Disorder; Clonazepam; Humans; Meta-Analysis as Topic | 2006 |
Long-term management of panic disorder.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Drug Toler | 1990 |
The diagnosis and treatment of adolescent anxiety disorders.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Child; | 1990 |
High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Fear; Huma | 1990 |
High anxiety in children.
Topics: Adult; Age Factors; Anxiety Disorders; Child; Clinical Trials as Topic; Clonazepam; Diazepam; Humans | 1990 |
Continuation treatment of panic disorder with high-potency benzodiazepines.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Benzodiazepines; Clonazepam; Humans; P | 1990 |
Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines.
Topics: Acute Disease; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clonazepam; Fear; Female; | 1987 |
Clonazepam: a review of open clinical trials.
Topics: Adult; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Female; Humans; Male; Middle Aged; P | 1987 |
14 trials available for clonazepam and Anxiety Disorders
| Article | Year |
|---|---|
Etifoxine is non-inferior than clonazepam for reduction of anxiety symptoms in the treatment of anxiety disorders: a randomized, double blind, non-inferiority trial.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Clonazepam; Double-Blind Method; Fe | 2020 |
Clinical efficacy of Manasamitra Vataka (an Ayurveda medication) on generalized anxiety disorder with comorbid generalized social phobia: a randomized controlled study.
Topics: Adult; Anxiety; Anxiety Disorders; Bacopa; Biological Products; Clonazepam; Depression; Disorders of | 2012 |
New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Bromazepam; C | 1983 |
Phenobarbital versus clonazepam for sedative-hypnotic taper in chronic pain patients. A pilot study.
Topics: Adult; Anxiety Disorders; Chronic Disease; Clonazepam; Double-Blind Method; Female; Hospitalization; | 1993 |
Treatment of recent trauma survivors with benzodiazepines: a prospective study.
Topics: Alprazolam; Anxiety Disorders; Arousal; Benzodiazepines; Clonazepam; Follow-Up Studies; Heart Rate; | 1996 |
[Treatment of autonomic crises (attacks of panic)].
Topics: Amitriptyline; Anxiety Disorders; Autonomic Nervous System Diseases; Clonazepam; Depressive Disorder | 1991 |
Low doses of clonazepam in the treatment of panic disorder.
Topics: Adult; Anxiety Disorders; Clonazepam; Dose-Response Relationship, Drug; Drug Administration Schedule | 1991 |
Long-term management of panic disorder.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Drug Toler | 1990 |
High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Fear; Huma | 1990 |
Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Ataxia; Clonazepam; Double-Blind Method; Female; Humans; Male; | 1991 |
Clonazepam and imipramine in the treatment of panic attacks: a double-blind comparison of efficacy and side effects.
Topics: Adult; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Double-Blind Method; Drug Administra | 1990 |
High anxiety in children.
Topics: Adult; Age Factors; Anxiety Disorders; Child; Clinical Trials as Topic; Clonazepam; Diazepam; Humans | 1990 |
Clonazepam: a review of open clinical trials.
Topics: Adult; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Female; Humans; Male; Middle Aged; P | 1987 |
Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Double | 1987 |
38 other studies available for clonazepam and Anxiety Disorders
| Article | Year |
|---|---|
A Tale of COVID-19: Beyond Physical Ailment.
Topics: Anxiety; Anxiety Disorders; Child; Clonazepam; Cognitive Behavioral Therapy; COVID-19; Diagnosis, Di | 2021 |
Tardive dystonia and tardive sensory syndrome related to trazodone: a case report.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Anxiety Disorders; Clonazepam; Dys | 2008 |
EEG complexity and attentional processes related to dissociative states.
Topics: Adult; Anticonvulsants; Anxiety Disorders; Arousal; Attention; Clonazepam; Dissociative Disorders; E | 2011 |
A case of quetiapine XR and divalproex-associated neutropenia followed by successful use of ziprasidone.
Topics: Adult; Anti-Anxiety Agents; Antimanic Agents; Antipsychotic Agents; Anxiety Disorders; Bipolar Disor | 2012 |
[Disguised Tourette's syndrome. A contribution to the differential diagnosis on phobia and fear].
Topics: Adult; Anxiety Disorders; Clomipramine; Clonazepam; Cognitive Behavioral Therapy; Combined Modality | 2002 |
Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Clonazepam; Cohort Studies; Depressive Disorder; Dose | 2004 |
Antipanic effect of clonazepam.
Topics: Anxiety Disorders; Benzodiazepinones; Clonazepam; Fear; Humans; Panic | 1984 |
[Ataractic treatment in psychiatry and general medicine. Overview of preparations, 3].
Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Chlorprothixene; Clobaza | 1983 |
Hepatitis secondary to fluoxetine treatment.
Topics: Adult; Anxiety Disorders; Chemical and Drug Induced Liver Injury; Clonazepam; Drug Therapy, Combinat | 1996 |
Treatment of palilalia with trazodone.
Topics: Adult; Anxiety Disorders; Chemical and Drug Induced Liver Injury; Clonazepam; Drug Therapy, Combinat | 1996 |
Social phobia and stuttering.
Topics: Anxiety Disorders; Clonazepam; Combined Modality Therapy; Humans; Male; Middle Aged; Phobic Disorder | 1996 |
The offensive subtype of Taijin-kyofu-sho in New York City: the phenomenology and treatment of a social anxiety disorder.
Topics: Adolescent; Adult; Anxiety Disorders; Benzamides; Clonazepam; Culture; Diagnosis, Differential; Ethn | 1996 |
The realities of clonazepam discontinuation.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Clonazepam; Drug Administration Schedule; GABA Modul | 1997 |
Clonazepam for psychiatric disorders? A look at its use in an inpatient psychiatric facility.
Topics: Anxiety Disorders; Clonazepam; Drug Utilization; Hospital Bed Capacity, under 100; Hospitals, Psychi | 1992 |
Treatment of Meige's syndrome with ECT.
Topics: Anxiety Disorders; Baclofen; Clonazepam; Combined Modality Therapy; Comorbidity; Depressive Disorder | 1999 |
[Treatment of patients with panic disorder and an elevated urinary excretion of MHPG using imipramine or clonazepam].
Topics: Adult; Anxiety Disorders; Clonazepam; Depression; Female; Humans; Imipramine; Lactates; Lactic Acid; | 1992 |
Flushing reaction associated with the interaction of phenelzine and clonazepam.
Topics: Adult; Anxiety Disorders; Clonazepam; Depressive Disorder; Dose-Response Relationship, Drug; Drug Th | 1991 |
Onset of panic disorder associated with rare use of cocaine.
Topics: Adult; Anxiety Disorders; Arousal; Clonazepam; Cocaine; Drug Administration Schedule; Humans; Male; | 1991 |
Sexual disinhibition during treatment with a benzodiazepine: a case report.
Topics: Anxiety Disorders; Clonazepam; Depressive Disorder; Female; Humans; Panic; Sexual Behavior; Social E | 1991 |
Clonazepam for the treatment of social phobia.
Topics: Adolescent; Adult; Anxiety Disorders; Clonazepam; Comorbidity; Drug Administration Schedule; Female; | 1990 |
Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study.
Topics: Alprazolam; Anxiety Disorders; Child, Preschool; Chronic Disease; Clonazepam; Cognitive Behavioral T | 1990 |
Interaction between clonazepam and phenelzine.
Topics: Adult; Anxiety Disorders; Clonazepam; Drug Interactions; Female; Headache; Humans; Panic; Phenelzine | 1990 |
Switching patients from alprazolam to clonazepam.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clonazepam; Dose-Response Relationship, Drug; Drug Admin | 1990 |
The diagnosis and treatment of panic disorder in alcoholics: three cases.
Topics: Adult; Alcohol Drinking; Alcoholism; Anxiety Disorders; Clonazepam; Diazepam; Follow-Up Studies; Hum | 1990 |
"Anger attacks": possible variants of panic and major depressive disorders.
Topics: Adult; Anger; Anxiety Disorders; Clomipramine; Clonazepam; Depressive Disorder; Desipramine; Diagnos | 1990 |
Sexual dysfunction associated with diazepam but not with clonazepam.
Topics: Adult; Anxiety Disorders; Clonazepam; Diazepam; Dose-Response Relationship, Drug; Erectile Dysfuncti | 1989 |
Clonazepam in the treatment of obsessive compulsive disorder associated with panic disorder in one patient.
Topics: Adult; Anxiety Disorders; Clonazepam; Fear; Humans; Lorazepam; Male; Obsessive-Compulsive Disorder; | 1989 |
Imipramine and clonazepam for panic disorder.
Topics: Anxiety Disorders; Clonazepam; Depressive Disorder; Drug Therapy, Combination; Fear; Humans; Imipram | 1989 |
Clonazepam blockade of spontaneous and CO2 inhalation-provoked panic in a patient with panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Carbon Dioxide; Clonazepam | 1986 |
Acute generalized myoclonus following buspirone administration.
Topics: Acute Disease; Akathisia, Drug-Induced; Anxiety Disorders; Buspirone; Clonazepam; Depressive Disorde | 1988 |
Alprazolam dependency: use of clonazepam for withdrawal.
Topics: Adult; Alprazolam; Anxiety Disorders; Clonazepam; Humans; Hydrocortisone; Male; Substance Withdrawal | 1988 |
The alprazolam to clonazepam switch for the treatment of panic disorder.
Topics: Alprazolam; Anxiety Disorders; Clonazepam; Fear; Humans; Panic | 1987 |
Clonazepam in the treatment of prepubertal children with panic-like symptoms.
Topics: Adolescent; Age Factors; Anxiety Disorders; Child; Clonazepam; Drug Administration Schedule; Fear; F | 1987 |
Treatment of panic disorder and agoraphobia with clonazepam.
Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepino | 1986 |
Successful use of clonazepam in patients with treatment-resistant panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Clonazepam; D | 1986 |
Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up.
Topics: Adolescent; Adult; Aged; Agoraphobia; Anxiety Disorders; Clonazepam; Fear; Female; Follow-Up Studies | 1986 |
Clonazepam in the treatment of patients with recurrent panic attacks.
Topics: Adult; Agoraphobia; Anxiety Disorders; Benzodiazepinones; Clonazepam; Drug Evaluation; Fear; Female; | 1986 |
Clonazepam in the treatment of recurrent symptoms of depression and anxiety in a patient with systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Adult; Anxiety Disorders; Benzodiazepinones; Clonazepam; Depressive Disorde | 1985 |